(S (NP (NN Warfarin) (NN dosing)) (VP (VBZ remains) (NP (ADJP (ADJP (JJ challenging) (PP (IN due) (PP (IN to) (NP (JJ narrow) (JJ therapeutic) (NN index))))) (CC and) (ADJP (RB highly) (JJ individual))) (NN variability))) (. .))
(S (NP (JJ Incorrect) (NN warfarin) (NN dosing)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (JJ devastating) (JJ adverse) (NNS events))))) (. .))
(S (NP (JJ Remarkable) (NNS efforts)) (VP (VBP have) (VP (VBN been) (VP (VBN made) (S (VP (TO to) (VP (VB develop) (NP (DT the) (NN machine) (NN learning)) (PP (VBN based) (NP (NP (NN warfarin) (NN dosing) (NNS algorithms)) (VP (VBG incorporating) (NP (NP (JJ clinical) (NNS factors)) (CC and) (NP (NP (JJ genetic) (NNS variants)) (PP (JJ such) (IN as) (NP (NP (NNS polymorphisms)) (PP (IN in) (NP (NN CYP2C9) (CC and) (NN VKORC1)))))))))))))))) (. .))
(S (NP (DT The) (ADJP (RBS most) (RB widely) (VBN validated)) (JJ pharmacogenetic) (NN algorithm)) (VP (VBZ is) (NP (NP (DT the) (NNP IWPC) (NN algorithm)) (PP (VBN based) (PP (IN on) (NP (JJ multivariate) (JJ linear) (NN regression))))) (PRN (-LRB- -LRB-) (NP (NNP MLR)) (-RRB- -RRB-))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN with) (NP (RB only) (DT a) (JJ single) (NN algorithm))) (, ,) (NP (DT the) (NN prediction) (NN performance)) (VP (MD may) (VP (VB reach) (NP (DT an) (JJ upper) (NN limit)) (ADVP (RB even)) (PP (IN with) (NP (JJ optimal) (NNS parameters))))) (. .))
(S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP present) (NP (JJ novel) (NNS algorithms)) (S (VP (VBG using) (VP (VBN stacked) (NP (NN generalization) (NNS frameworks)) (S (VP (TO to) (VP (VB estimate) (NP (NP (DT the) (NN warfarin) (NN dose)) (, ,) (SBAR (WHPP (IN within) (WHNP (WDT which))) (S (NP (NP (JJ different) (NNS types)) (PP (IN of) (NP (NML (NN machine) (NN learning)) (NNS algorithms)))) (VP (VBP function) (ADVP (RB together)) (PP (IN through) (NP (DT a) (NML (NN meta) (HYPH -) (NN machine)) (NN learning) (NN model))) (S (VP (TO to) (VP (VB maximize) (NP (DT the) (NN prediction) (NN accuracy)))))))))))))))) (. .))
(S (PP (VBN Compared) (PP (IN to) (NP (DT the) (ADJP (NP (NN IWPC)) (HYPH -) (VBN derived)) (NNP MLR) (NN algorithm)))) (, ,) (NP (NP (NN Stack) (CD 1)) (CC and) (NP (CD 2) (ADJP (VBN based) (PP (IN on) (S (VP (VBN stacked))))) (NN generalization) (NNS frameworks))) (VP (VBD performed) (ADJP (RB significantly) (JJR better)) (ADVP (JJ overall))) (. .))
(S (NP (JJ Subgroup) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (DT the) (NN mean)) (PP (IN of) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP$ whose)) (S (VP (VBD predicted) (NP (NP (NN dose)) (PP (IN of) (NP (NN warfarin)))) (PP (IN within) (NP (NP (CD 20) (NN %)) (PP (IN of) (NP (DT the) (JJ actual) (JJ stable) (JJ therapeutic) (NN dose))))) (PRN (-LRB- -LRB-) (S (VP (VB mean) (NP (NN percentage)) (PP (IN within) (NP (CD 20) (NN %))))) (-RRB- -RRB-))))))))) (PP (IN for) (NP (NN Stack) (CD 1)))) (VP (VBD was) (VP (VBN improved) (PP (IN by) (NP (NP (CD 12.7) (NN %)) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 42.47) (NN %) (IN to) (CD 47.86) (NN %)))) (-RRB- -RRB-))) (PP (PP (IN in) (NP (NNPS Asians))) (CC and) (PP (IN by) (NP (CD 13.5) (NN %)))) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 22.08) (NN %) (IN to) (CD 25.05) (NN %)))) (-RRB- -RRB-) (PP (IN in) (NP (NP (DT the) (NML (JJ low) (HYPH -) (NN dose)) (NN group)) (PP (VBN compared) (PP (PP (IN to) (NP (NP (DT that)) (PP (IN for) (NP (NNP MLR))))) (, ,) (ADVP (RB respectively))))))))))) (. .))
(S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (PRP$ our) (NNS algorithms)) (VP (MD would) (ADVP (RB especially)) (VP (VB benefit) (NP (NP (NNS patients)) (VP (VBN required) (ADVP (RB low)) (NP (NML (NN warfarin) (NN maintenance)) (NN dose)) (, ,) (SBAR (IN as) (S (NP (NP (JJ subtle) (NNS changes)) (PP (IN in) (NP (NN warfarin) (NN dose)))) (VP (MD could) (VP (VB lead) (PP (IN to) (NP (JJ adverse) (JJ clinical) (NNS events))))))) (PRN (-LRB- -LRB-) (NP (NN thrombosis) (CC or) (NN bleeding)) (-RRB- -RRB-)))) (PP (IN in) (NP (NNS patients))) (PP (IN with) (NP (JJ low) (NN dose)))))))) (. .))
(S (NP (PRP$ Our) (NN study)) (VP (VBZ offers) (NP (NP (JJ novel) (JJ pharmacogenetic) (NNS algorithms)) (PP (IN for) (NP (JJ clinical) (NNS trials) (CC and) (NN practice))))) (. .))
